Related MeSH Hierarchy (9)
Diseases [C] » Infections [C01] » Communicable Diseases » Blood-Borne Infections » HIV Infections » HIV Wasting Syndrome
Diseases [C] » Infections [C01] » Communicable Diseases » Sexually Transmitted Diseases » Sexually Transmitted Diseases, Viral » HIV Infections » HIV Wasting Syndrome
Diseases [C] » Infections [C01] » Sexually Transmitted Diseases » Sexually Transmitted Diseases, Viral » HIV Infections » HIV Wasting Syndrome
Diseases [C] » Urogenital Diseases [C12] » Genital Diseases » Sexually Transmitted Diseases » Sexually Transmitted Diseases, Viral » HIV Infections » HIV Wasting Syndrome
Diseases [C] » Infections [C01] » Virus Diseases » RNA Virus Infections » Retroviridae Infections » Lentivirus Infections » HIV Infections » HIV Wasting Syndrome
Diseases [C] » Infections [C01] » Virus Diseases » Sexually Transmitted Diseases, Viral » HIV Infections » HIV Wasting Syndrome
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Wasting Syndrome » HIV Wasting Syndrome
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Nutrition Disorders » Wasting Syndrome » HIV Wasting Syndrome
Diseases [C] » Immune System Diseases [C20] » Immunologic Deficiency Syndromes » HIV Infections » HIV Wasting Syndrome
Description
Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. (From Harrison's Principles of Internal Medicine, 13th ed, p1611). MeSH
Hierarchy View
Approved Indicated Drugs (1)
Phase 3 Indicated Drugs (1)
Phase 2 Indicated Drugs (3)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
